Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Colorcon
Merck
McKesson
McKinsey

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Iclaprim

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Iclaprim: Sponsors, patents, clinical trial progress

Iclaprim is an investigational drug.

There have been 5 clinical trials for Iclaprim. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2006.

The most common disease conditions in clinical trials are Infection, Soft Tissue Infections, and Communicable Diseases. The leading clinical trial sponsors are Arpida AG, Motif Bio, and [disabled in preview].

Recent Clinical Trials for Iclaprim
TitleSponsorPhase
Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1Motif BioPhase 3
Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2Motif BioPhase 3
Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated PneumoniaArpida AGPhase 2

See all Iclaprim clinical trials

Clinical Trial Summary for Iclaprim

Top disease conditions for Iclaprim
Top clinical trial sponsors for Iclaprim

See all Iclaprim clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Merck
Dow
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.